Revance Therapeutics Inc. (RVNC) Slipped -5.28% or -1.8 To Price $32.3 On Wednesday


Revance Therapeutics Inc. (RVNC) slipped -5.28% or -1.8 to $32.3. It is near to 456923 shares traded, which is 120.13% compare to the average total volume 380344. The market cap of RVNC is $1.18 billion. The year to date change is -8.82%. The 52 week price range is from $18.0 to $37.45. Price of RVNC have changed 0.89% during last week. It have changed -8.82% over last month, 27.00% over last 3 months, 49.89% over last 6 months and 77.60% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RVNC is 32.41. It is 0.34% above current price. The stock faces resistance at 50-day moving averages. The 200-day Moving Averages for RVNC is 26.12. It is -19.13% below current price. The 52-week High is 37.45. It is 15.94% from the current price. The 52-week Low is 18.0. It is -44.27% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of RVNC is 4.09 on 2018-01-12. Short % to float is 5.31%. There are some statistics of RVNC. It is has market cap $1.18 billion. The share outstanding is 36.50 million. The average volume is 380344. The revenue is 300000. The percent of top 15 Institution holding is 83.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RVNC is -65.05%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RVNC is -56.30%.


Tags:

Share this post